Stevens-Johnson Syndrome Latest Advances

Stevens-Johnson syndrome and toxic epidermal necrolysis: diagnosis and management in the emergency department.

Journal: Emergency medicine practice

Published: June 22, 2026

Severe Mycoplasma-induced Rash and Mucositis Mimicking Stevens-Johnson Syndrome Treated With Steroid Pulse Therapy: A Case Highlighting Diagnostic Challenges and Therapeutic Considerations.

Journal: The Pediatric infectious disease journal

Published: June 19, 2026

An update on our understanding of host defense mechanisms at the ocular surface; innate immune dysregulation at the ocular surface: lessons from Stevens-Johnson syndrome and related inflammatory disorders.

Journal: Expert review of clinical immunology

Published: June 17, 2026

Immunological Interplay at the Ocular Surface of Stevens-Johnson Syndrome, Ocular Cicatricial Pemphigoid, and Ocular Graft Versus Host Disease.

Journal: Investigative ophthalmology & visual science

Published: June 15, 2026

Possible Diclofenac-Related Fulminant Toxic Epidermal Necrolysis: A Case Report.

Journal: Cureus

Published: June 15, 2026

Drug-induced multisystem syndromes: An overlooked challenge in pharmacovigilance.

Journal: The International journal of risk & safety in medicine

Published: June 15, 2026

Incidence and Factors Associated With In-Hospital Mortality in Adult Patients With Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis: A Nationwide Thai Cohort.

Journal: Journal of cutaneous medicine and surgery

Published: June 11, 2026

KEY POINTS FOR DRUG ERUPTIONS IN DAILY PRACTICE

Journal: Arerugi = [Allergy]

Published: June 10, 2026

Generalized Bullous Fixed-Drug Eruption in a 15-Year-Old Child With Becker Muscular Dystrophy and Epilepsy.

Journal: Journal of drugs in dermatology : JDD

Published: June 03, 2026

Hydroxychloroquine Sulfate-Associated Skin Lesions: Clinical Features and Mechanisms.

Journal: The Journal of rheumatology

Published: June 01, 2026

What Are the Systemic Therapeutic Options for Paediatric Stevens Johnson Syndrome (SJS) and Toxic Epidermal Necrolysis (TEN)?

Journal: Journal of paediatrics and child health

Published: May 27, 2026

A case of severe bullous drug eruption resembling Stevens-Johnson syndrome after nivolumab and tegafur-gimeracil-oteracil administration with lymphocytic infiltration into the eccrine ducts and distinctive re-epithelialization features.

Journal: European journal of dermatology : EJD

Published: May 25, 2026

Stevens-Johnson Syndrome Latest Advances

Find the Latest Research About Stevens-Johnson Syndrome

Stevens-Johnson syndrome and toxic epidermal necrolysis: diagnosis and management in the emergency department.

Stevens-Johnson syndrome and toxic epidermal necrolysis: diagnosis and management in the emergency department.

Severe Mycoplasma-induced Rash and Mucositis Mimicking Stevens-Johnson Syndrome Treated With Steroid Pulse Therapy: A Case Highlighting Diagnostic Challenges and Therapeutic Considerations.

Severe Mycoplasma-induced Rash and Mucositis Mimicking Stevens-Johnson Syndrome Treated With Steroid Pulse Therapy: A Case Highlighting Diagnostic Challenges and Therapeutic Considerations.

An update on our understanding of host defense mechanisms at the ocular surface; innate immune dysregulation at the ocular surface: lessons from Stevens-Johnson syndrome and related inflammatory disorders.

An update on our understanding of host defense mechanisms at the ocular surface; innate immune dysregulation at the ocular surface: lessons from Stevens-Johnson syndrome and related inflammatory disorders.

Immunological Interplay at the Ocular Surface of Stevens-Johnson Syndrome, Ocular Cicatricial Pemphigoid, and Ocular Graft Versus Host Disease.

Immunological Interplay at the Ocular Surface of Stevens-Johnson Syndrome, Ocular Cicatricial Pemphigoid, and Ocular Graft Versus Host Disease.

Possible Diclofenac-Related Fulminant Toxic Epidermal Necrolysis: A Case Report.

Possible Diclofenac-Related Fulminant Toxic Epidermal Necrolysis: A Case Report.

Drug-induced multisystem syndromes: An overlooked challenge in pharmacovigilance.

Drug-induced multisystem syndromes: An overlooked challenge in pharmacovigilance.

Incidence and Factors Associated With In-Hospital Mortality in Adult Patients With Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis: A Nationwide Thai Cohort.

Incidence and Factors Associated With In-Hospital Mortality in Adult Patients With Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis: A Nationwide Thai Cohort.

KEY POINTS FOR DRUG ERUPTIONS IN DAILY PRACTICE

KEY POINTS FOR DRUG ERUPTIONS IN DAILY PRACTICE

Generalized Bullous Fixed-Drug Eruption in a 15-Year-Old Child With Becker Muscular Dystrophy and Epilepsy.

Generalized Bullous Fixed-Drug Eruption in a 15-Year-Old Child With Becker Muscular Dystrophy and Epilepsy.

Hydroxychloroquine Sulfate-Associated Skin Lesions: Clinical Features and Mechanisms.

Hydroxychloroquine Sulfate-Associated Skin Lesions: Clinical Features and Mechanisms.

What Are the Systemic Therapeutic Options for Paediatric Stevens Johnson Syndrome (SJS) and Toxic Epidermal Necrolysis (TEN)?

What Are the Systemic Therapeutic Options for Paediatric Stevens Johnson Syndrome (SJS) and Toxic Epidermal Necrolysis (TEN)?

A case of severe bullous drug eruption resembling Stevens-Johnson syndrome after nivolumab and tegafur-gimeracil-oteracil administration with lymphocytic infiltration into the eccrine ducts and distinctive re-epithelialization features.

A case of severe bullous drug eruption resembling Stevens-Johnson syndrome after nivolumab and tegafur-gimeracil-oteracil administration with lymphocytic infiltration into the eccrine ducts and distinctive re-epithelialization features.